These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1605652)
41. Can we increase survival in breast cancer with innovative applications of conventional drugs? Swain SM; Harris LN Eur J Cancer; 1994; 30A(4):423-4. PubMed ID: 8018395 [No Abstract] [Full Text] [Related]
42. [Usefulness of contact thermography for the evaluation of chemotherapeutic effectiveness in breast cancer]. Kurihara T; Higashi Y; Suemasu K; Kanoh T; Tabei T; Inoue K Gan To Kagaku Ryoho; 1993 May; 20(7):915-20. PubMed ID: 8489298 [TBL] [Abstract][Full Text] [Related]
43. Doxorubicin adjuvant combinations for breast cancer. Sauter C Lancet; 1993 Dec 18-25; 342(8886-8887):1550-1. PubMed ID: 7902917 [No Abstract] [Full Text] [Related]
44. ASCO debates high-dose chemotherapy. American Society of Clinical Oncology. Astrow AB Lancet; 1994 Jun; 343(8911):1493. PubMed ID: 7911187 [No Abstract] [Full Text] [Related]
45. How to improve cytotoxic therapy in advanced breast cancer. Bastholt L; Mouridsen HT Acta Oncol; 1990; 29(3):349-55. PubMed ID: 2194536 [TBL] [Abstract][Full Text] [Related]
46. Chemotherapy for metastatic breast cancer. Barni S; MandalĂ M Ann Oncol; 2005 May; 16 Suppl 4():iv23-27. PubMed ID: 15923425 [No Abstract] [Full Text] [Related]
47. High-dose chemotherapy for breast cancer. Triozzi PL; Rhoades C; Thornton DE Cancer Treat Rev; 1995 May; 21(3):185-98. PubMed ID: 7656264 [No Abstract] [Full Text] [Related]
48. Achievable survival in breast cancer. Greenspan EM J Natl Cancer Inst; 1992 May; 84(10):811. PubMed ID: 1573672 [No Abstract] [Full Text] [Related]
49. Unanswered questions in the adjuvant therapy of breast cancer. Dorr FA; Friedman MA Cancer Treat Res; 1992; 60():257-78. PubMed ID: 1355990 [No Abstract] [Full Text] [Related]
50. Overview of the six available randomized trials of high-dose chemotherapy with blood or marrow transplant in breast cancer. Antman KH J Natl Cancer Inst Monogr; 2001; (30):114-6. PubMed ID: 11773303 [No Abstract] [Full Text] [Related]
51. Survival in advanced breast cancer. Combination chemotherapy improves outlook. Price LA BMJ; 1994 Apr; 308(6936):1103. PubMed ID: 8173443 [No Abstract] [Full Text] [Related]
52. Dose response in the treatment of breast cancer. Stewart TH; Retsky MW; Tsai SC; Verma S Lancet; 1994 Feb; 343(8894):402-4. PubMed ID: 7905558 [TBL] [Abstract][Full Text] [Related]
53. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J; J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969 [TBL] [Abstract][Full Text] [Related]
54. [Significance of cytostatic drug dose in adjuvant chemotherapy of breast carcinoma]. Thomssen C Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M102-5. PubMed ID: 8964443 [No Abstract] [Full Text] [Related]
55. [Chemotherapy of advanced breast cancer]. Ogawa M Gan To Kagaku Ryoho; 1992 Jun; 19(6):769-74. PubMed ID: 1605652 [TBL] [Abstract][Full Text] [Related]
56. [Treatment strategy to obtain cure for recurrent advanced breast cancer]. Ogawa M; Mukaiyama T Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():259-63. PubMed ID: 7518661 [TBL] [Abstract][Full Text] [Related]
57. [CMF or CAF combination chemotherapy for breast cancer]. Ota J Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791 [TBL] [Abstract][Full Text] [Related]